Thomas Loeser

Thomas Loeser has extensive experience in financial leadership and advisory roles within the healthcare and biopharmaceutical sectors. Currently serving as Managing Partner at Viopas Venture Consulting GmbH, Thomas Loeser focuses on providing tailored services to healthcare companies and investors. As a Senior Financial Advisor at Bioscience Valuation since November 2019, expertise lies in analyzing financial and life sciences intersections. Previous positions include Chief Financial Officer at T-CURX GmbH, CFO at Origenis GmbH, and Interim CFO at eADMET GmbH. Thomas Loeser also founded TL Asset & Interim Management, specializing in asset management for biotech companies. Early career achievements include critical roles at ESBATech and Morphochem AG, where significant fundraising and company expansions were accomplished. Educational background includes studies in economics at Ludwig-Maximilians-Universität München and completion of the Advanced Management Program at Harvard Business School.